Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking

Biochemistry

Volumn 38, Issue 34, 1999, Pages 10997-11005

  Kašpárková, Jana ^a   Nováková, Olga ^a   Vrána, Oldřich ^a   Farrell, Nicholas ^b   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DNA; PLATINUM COMPLEX; TRANSPLATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CIRCULAR DICHROISM; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DNA BASE COMPOSITION; DNA CROSS LINKING; DNA DRUG COMPLEX; DNA TRANSCRIPTION; DRUG DNA BINDING; DRUG STRUCTURE; ISOMERISM; PRIORITY JOURNAL; RNA SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CIRCULAR DICHROISM; CISPLATIN; CROSS-LINKING REAGENTS; DNA ADDUCTS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; NUCLEIC ACID HETERODUPLEXES; OLIGODEOXYRIBONUCLEOTIDES; STEREOISOMERISM; TRANSCRIPTION, GENETIC;

EID: 0033600598     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi990245s     Document Type: Article

References (37)

1. Lepre, C. A., and Lippard, S. J. (1990) Nucleic Acids Mol. Biol. 4, 9-38.
2. Reedijk, J. (1996) Chem. Commun., 801-806.
3. Johnson, N. P., Butour, J.-L., Villani, G., Wimmer, F. L., Defais, M., Pierson, V., and Brabec, V. (1989) Prag. Clin. Biochem. Med. 10, 1-24.
4. Tilby, M. J., Johnson, C., Knox, R. J., Cordell, J., Roberts, J. J., and Dean, C. J. (1991) Cancer Res. 57, 123-129.
5. Blommaert, F. A., van Dijk-Knijnenburg, H. C. M., Dijt, F. J., Denengelse, L., Baan, R. A., Berends, F., and Fichtinger-Schepman, A. M. J. (1995) Biochemistry 34, 8474-8480.
6. Lokich, J., and Anderson, N. (1998) Ann. Oncol. 9, 13-21.
7. Farrell, N. (1996) in Advances in DNA sequence specific agents (Hurley, L. H., and Chaires, J. B., Eds.) pp 187-216, JAI Press Inc., New Haven, CT.
8. Farrell, N., Qu, Y., and Hacker, M. P. (1990) J. Med. Chem. 33, 2179-2184.
9. Farrell, N. (1993) Cancer Invest. 11, 578-589.
10. Manzotti, C., Pezzoni, G., Guiliani, F., Valsecchi, M., Farrell, N., and Tognella, S. (1994) Proc. Am. Assn. Cancer Res. 35, 2628.
11. Farrell, N., Appleton, T. G., Qu, Y., Roberts, J. D., Fontes, A. P. S., Skov, K. A., Wu, P., and Zou, Y. (1995) Biochemistry 34, 15480-15486.
12. Farrell, N., Qu, Y., Bierbach, U., Valsecchi, M., and Menta, E. (1999) in 30 Years of Cisplatin-Chemistry and Biochemistry of a Leading Anticancer Drug (Lippert, B., Ed.) pp 479-496, Verlag CH, Basel, Switzerland.
13. Johnson, A. L., Illenye, S., Farrell, N., and Van Houten, B. (1994) Proc. Am. Assn. Cancer Res. 35, 2634.
14. Mellish, K. J., Qu, Y., Scarsdale, N., and Farrell, N. (1997) Nucleic Acids Res. 25, 1265-1271.
15. Lehnen, S., and Farrell, N. (1995) Proc. Am. Assn. Cancer Res. 36, 2376.
16. Roberts, J., Peroutka, J., and Farrell, N. (1997) Proc, Am. Assn. Cancer Res. 38, 2081.
17. Brabec, V., and Paleček, E. (1970) Biophysik 6, 290-300.
18. Brabec, V., and Paleček, E. (1976) Biophys. Chem. 4, 76-92.
19. Lemaire, M. A., Schwartz, A., Rahmouni, A. R., and Leng, M. (1991) Proc. Natl. Acad. Sei. U.S.A. 88, 1982-1985.
20. Kim, S. D., Vrána, O., Kleinwächter, V., Niki, K., and Brabec, V. (1990) Anal. Lett. 23, 1505-1518.
21. Brabec, V., Reedijk, J., and Leng, M. (1992) Biochemistry 31, 12397-12402.
22. Brabec, V., and Leng, M. (1993) Proc. Natl. Acad. Sei. U.S.A. 90, 5345-5349.
23. Maxam, A. M., and Gilbert, W. (1980) Methods Enzymol. 65, 499-560.
24. Comess, K. M., Costello, C. E., and Lippard, S. J. (1990) Biochemistry 29, 2102-2110.
25. Butour, J. L., and Macquet, J. P. (1977) Eur. J. Biochem. 78, 455-463.
26. Butour, J. L., Alvinerie, P., Souchard, J. P., Colson, P., Houssier, C., and Johnson, N. P. (1991) Eur. J. Biochem. 202, 975-980.
27. Žaludová, R., Žákovská, A., Kašpárková, J., Balcarová, Z., Kleinwächter, V., Vrána, O., Farrell, N., and Brabec, V. (1997) Eur. J. Biochem. 246, 508-517.
28. Corda, Y., Job, C., Anin, M. F., Leng, M., and Job, D. (1991) Biochemistry 30, 222-230.
29. Corda, Y., Anin, M. F., Leng, M., and Job, D. (1992) Biochemistry 31, 1904-1908.
30. Brabec, V., Boudný, V., and Balcarová, Z. (1994) Biochemistry 33, 1316-1322.
31. Novákovd, O., Vrána, O., Kiseleva, V. I., and Brabec, V. (1995) Eur. J. Biochem. 228, 616-624.
32. Ivanov, V. I., Minchenkova, L. E., Minyat, E. E., Frank-Kamenetskii, M. D., and Schyolkina, A. K. (1974) J. Mol. Biol.87, 817-833.
33. Vorlíčková, M. (1995) Biophys. J. 69, 2033-2043.
34. Žaludová, R., Kleinwächter, V., and Brabec, V. (1996) Biophys. Client. 60, 135-142.
35. Lepre, C. A., Chassot, L., Costello, C. E., and Lippard, S. J. (1990) Biochemistry 29, 811-823.
36. Dalbies, R., Payet, D., and Leng, M. (1994) Proc. Natl. Acad. Sei. U.S.A. 97,8147-8151.
37. Johnson, N. P., Mazard, A. M., Escalier, J., and Macquet, J. P. (1985) J. Am. Chem. Soc. 107, 6376-6380.